Scancell Holdings Share News (SCLP)

UK AGM, EGM Calendar - Week Ahead

UK AGM, EGM Calendar - Week Ahead

UK AGM, EGM Calendar - Week Ahead

UK AGM, EGM Calendar - Week Ahead

UK AGM, EGM Calendar - Week Ahead

UK AGM, EGM Calendar - Week Ahead

UK AGM, EGM Calendar - Week Ahead

Scancell Holdings sees annual losses widen

Scancell Holdings, a developer of novel immunotherapies for the treatment of cancer, made an annual loss of £2.22m in the year to 30 April compared to £1.9m last year. The company development spending increased due to additional costs in pre-clinical studies for a new platform technology, while adm

Scancell Full-Year Loss Widens On Development, Administrative Costs

UK MIDDAY BRIEFING: Serco CEO Bolsters Top Team Again

UK WINNERS & LOSERS: Just Eat Delivers Tasty Revenue Growth

Scancell Boosted By Positive Results SCIB1, PD-1 Combination

UK MORNING BRIEFING: Just Eat Leads Mixed Market On Mobile Sales

Scancell Holdings ImmunoBody technology receives US approval

AIM-listed Pharmaceuticals group Scancell Holdings announced a patent for its DNA ImmunoBody technology has been approved in the US. The patent has been granted by the United States Patent and Trademark Office (USPTO) and covers Scancell's DNA ImmunoBody platform technology. This patent is expect

Scancell Granted US Patent For DNA Immunobody Technology

LONDON (Alliance News) - Scancell Holdings PLC said Friday its DNA Immunobody technology platform had been granted a patent by the US Patent and Trademark Office. Scancell said the patent was key for the protection of its pipeline of vaccines utilising the technology. It has already been gr